HYFT MindWalk Therapeutics: Accounting Value per Share

Growth in B2B subscriptions and the implementation of BioStrand for antibody analysis are driving the capitalization of MindWalk Holdings (HYFT). Tracking the book value per share on GURU.Markets, we note that the level of 0.10 is the current value. The development of an AI ecosystem in biopharmaceuticals accelerates drug discovery, establishing an intellectual foundation. Amid intense competition, MindWalk Holdings (HYFT) is developing highly specialized solutions to protect its patent advantage.

MindWalk Holdings, Inc. (HYFT): Share Book Value from 09/05/2025 to 10/29/2026

ipatherapeutics.com - analytical breakdowns and key metrics (HYFT)

- price and consensus price forecast:

Stock Price MindWalk|HYFT - Forecast Levels Chart

- market capitalization data:

Market Valuation MindWalk Holdings Inc.|HYFT - Aggregate Business Value

- book capitalization data:

Net Assets per Single Share MindWalk Holdings|HYFT - Net Asset Value|Market Capitalization to Book Value Ratio ipatherapeutics.com|HYFT - Aggregate Asset Value

- debt and liquidity data:

Fundamental company valuation:MindWalk - HYFT

Manufactured products of MindWalk Holdings Inc.

Capital control is critical for MindWalk Holdings (HYFT), as the company relies on external financing to implement medical AI solutions. The current book value per share reflects the net asset value per security, allowing for an assessment of real assets minus liabilities, which helps investors determine the business's fundamental value on the chart despite the risks associated with a lack of stable revenue.

Competitors of MindWalk Holdings (HYFT)

Book Value per Share Haleon Group|Kenvue Health (KVUE) - Share Book Value|VRNA - Accounting Value per Share|MENS (jyongbio.com) - Book Price of a Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share SXT China SXTC|EPRX - Book Price of a Share|Book Value per Share BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of a Share|Book Value per Share ORMP (Oramed)|Net Asset Value per Share ENTX|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share CPIX (cumberlandpharma.com)|Quantum BioPharma - Net Assets per Single Share|Accounting Value per Share FibroGen Inc FGEN|Book Value per Share TELO (Telomir Pharma)|RANI: Net Assets per Share|Net Assets per Single Share synergychc.com|Rallybio (RLYB) - Equity per Share|Book Value per Share Lexaria Bioscience Corp (LEXX)|Equity per Share Pulmatrix Inc (PULM)|Accounting Value per Share PTHL (Pheton Holdings Ltd)|Accounting Value per Share aptorumgroup.com (APM)|Book Value per Share LYRA (Lyra Therapeutics, Inc.)|Impact BioMedical, Inc. - Book Value per Share|TNFA - Net Assets per Single Share|YCBD: Net Assets per Single Share|PRFX: Net Assets per Single Share|Book Value per Share Altamira Therapeutics Ltd.|LIPO - Accounting Value per Share|Accounting Value of a Share optinose.com|Pieris Pharmaceuticals, Inc. (PIRS) - Book Value per Share|Accounting Value of a Share PROC (Procaps Group)|PTPI: Net Assets per Single Share|Qilian International Corp - Net Asset Value per Share|SLRN - Net Assets per Single Share|TFFP - Net Assets per Single Share